- Home
- CTLT vs JLL Comparison
CTLT vs JLL Comparison
Compare CTLT & JLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTLT
- JLL
- Stock Information
- Founded
- CTLT 2007
- JLL 1997
- Country
- CTLT United States
- JLL United States
- Employees
- CTLT N/A
- JLL N/A
- Industry
- CTLT Biotechnology: Pharmaceutical Preparations
- JLL Real Estate
- Sector
- CTLT Health Care
- JLL Finance
- Exchange
- CTLT Nasdaq
- JLL Nasdaq
- Market Cap
- CTLT 11.1B
- JLL 12.8B
- IPO Year
- CTLT 2014
- JLL 1997
- Fundamental
- Price
- CTLT $63.48
- JLL $268.73
- Analyst Decision
- CTLT Hold
- JLL Strong Buy
- Analyst Count
- CTLT 6
- JLL 7
- Target Price
- CTLT $63.40
- JLL $301.57
- AVG Volume (30 Days)
- CTLT 3.3M
- JLL 292.9K
- Earning Date
- CTLT 02-07-2025
- JLL 11-06-2024
- Dividend Yield
- CTLT N/A
- JLL N/A
- EPS Growth
- CTLT N/A
- JLL 109.45
- EPS
- CTLT N/A
- JLL 9.89
- Revenue
- CTLT $4,422,000,000.00
- JLL $22,503,400,000.00
- Revenue This Year
- CTLT $8.77
- JLL N/A
- Revenue Next Year
- CTLT $8.42
- JLL $9.58
- P/E Ratio
- CTLT N/A
- JLL $25.82
- Revenue Growth
- CTLT 4.71
- JLL 9.86
- 52 Week Low
- CTLT $42.07
- JLL $167.11
- 52 Week High
- CTLT $63.50
- JLL $288.50
- Technical
- Relative Strength Index (RSI)
- CTLT 74.48
- JLL 48.14
- Support Level
- CTLT $63.02
- JLL $267.76
- Resistance Level
- CTLT $63.25
- JLL $275.22
- Average True Range (ATR)
- CTLT 0.41
- JLL 5.45
- MACD
- CTLT 0.17
- JLL -1.02
- Stochastic Oscillator
- CTLT 99.29
- JLL 11.85
About CTLT Catalent Inc.
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
About JLL Jones Lang LaSalle Incorporated
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $74 billion for clients across diverse public and private real estate strategies.